Mood stabilizers and teratogenicity–prescribing practice and awareness amongst practising psychiatrists

References

• Adab N., Kini U., Vinten J., Ayres J., Baker G., Clayton-Smith J., Coyle H., Fryer A., Gorry J., Gregg J., Mawer G., Nicolaides P., Pickering L., Tunnicliffe L., Chadwick D. W. The longer term outcome of children born to mothers with epilepsy. Journal of Neurology, Neurosurgery & Psychiatry 2004; 75: 1575–1583
   PubMed Web of Science ®Google Scholar
• Cohen L. S., Friedman J. M., Jefferson J. W., Johnson E. M., Weiner M. L. A reevaluation of risk of in utero exposure to lithium. Journal of the American Medical Association 1994; 271: 146–150
   PubMedGoogle Scholar
• Czeizel A. E. Folic acid and the prevention of neural-tube defects. New England Journal of Medicine 2004; 350: 2209–2211
   PubMedGoogle Scholar
• Datapharm Communications Ltd. Electronic Medicines Compendium. http://medguides.medicines.org.uk/.2006
   Google Scholar
• Edmonds L. D., Oakley G. P. Ebstein's anomaly and maternal lithium exposure during pregnancy. Teratology 1990; 41: 551–552
   Google Scholar
• Ferrier I. N. Development in mood stabilisers. British Medical Bulletin 2001; 57: 179–192
   PubMedGoogle Scholar
• Green N. S. Folic acid supplementation and prevention of birth defects. Journal of Nutrition 2002; 132: 2356S–2360S
   PubMed Web of Science ®Google Scholar
• Goodwin G. M., for the Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 2003; 17: 149–173
   PubMed Web of Science ®Google Scholar
• Holmes L. B., Wyszynski D., Baldwin E. J., Haebecker E., Glassman L. H., Smith C. R. Increased risk for non-syndromic cleft palate among infants exposed to lamotrigine during pregnancy. Birth Defects Research 2006; 76: 318
   Google Scholar
• Jacobson S. J., Jones K., Johnson K., Ceolin L., Kaur P., Sahn D., Donnenfeld A. E., Rieder M., Santelli R., Smythe J. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992; 339: 530–533
   PubMed Web of Science ®Google Scholar
• James L., Barnes T. R. E., Lelliott P., Taylor D., Paton C. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists. Journal of Psychopharmacology 2007; 21: 815–819
   PubMed Web of Science ®Google Scholar
• Jones K. L., Lacro R. V., Johnson K. A., Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. New England Journal of Medicine 1989; 320: 1661–1666
   PubMed Web of Science ®Google Scholar
• Morrow J., Russell A., Guthrie E., Parsons L., Robertson I., Waddell R., Irwin B., McGivern R. C., Morrison P. J., Craig J. Malformation risks of antiepileptic drugs in pregnancy: A prospective study from the UK Epilepsy and Pregnancy Register. Journal of Neurology, Neurosurgery & Psychiatry 2006; 77: 193–198
   PubMed Web of Science ®Google Scholar
• National Institute of Clinical Excellence. The clinical effectiveness and cost effectiveness of new drugs for bi-polar disorder. 2003, Technical Appraisal 66. http://www.nice.org.uk
   Google Scholar
• National Institute of Clinical Excellence. The clinical effectiveness and cost effectiveness of newer drugs for epilepsy in adults. 2004, Technology Appraisal 76. http://www.nice.org.uk
   Google Scholar
• National Institute for Health and Clinical Excellence. Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. 2006, NICE Clinical Guideline 38, July 2006
   Google Scholar
• Omtzigt J. G., Los F. J., Hagenaars A. M., Stewart P. A., Sachs E. S., Lindhout D. Prenatal diagnosis of spina bifida aperta after first-trimester valproate exposure. Prenatal Diagnosis 1992; 12: 893–897
   PubMedGoogle Scholar
• Rosa F. W. Spina bifida in infants of women treated with carbamazepine during pregnancy. New England Journal of Medicine 1991; 324: 674–677
   PubMed Web of Science ®Google Scholar
• Vinten J., Adab N., Kini U., Gorry J., Gregg J., Baker G. A. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005; 64: 949–954
   PubMed Web of Science ®Google Scholar
• Wyszynski D. F., Nambisan M., Surve T., Alsdorf R. M., Smith C. R., Holmes L. B. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005; 64: 961–965
   PubMed Web of Science ®Google Scholar